StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Schrödinger, Inc.
NasdaqGS:SDGR
Sector
Location
Market Cap
USD 1.57 B
Share Price
USD 21.45
Avg Daily Volume
1,308,276
Change (1 day)
-0.92%
Change (1 year)
-1.56%
Change (YTD)
11.20%
Schrödinger, Inc. Shareholders' Equity for the year ending December 31, 2024: USD 421.44 M
Schrödinger, Inc. Shareholders' Equity is USD 421.44 M for the year ending December 31, 2024, a -23.17% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Schrödinger, Inc. Shareholders' Equity for the year ending December 31, 2023 was USD 548.56 M, a 22.47% change year over year.
-
Schrödinger, Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 447.89 M, a -19.60% change year over year.
-
Schrödinger, Inc. Shareholders' Equity for the year ending December 31, 2021 was USD 557.07 M, a -10.73% change year over year.
-
Schrödinger, Inc. Shareholders' Equity for the year ending December 31, 2020 was USD 624.01 M, a -768.37% change year over year.
Competitors
Natera, Inc.
USD 138.90
NTRA
-4.48
-3.12%
Illumina, Inc.
USD 96.14
ILMN
-1.79
-1.83%
Tempus AI, Inc.
USD 60.98
TEM
+0.33
0.54%
Veracyte, Inc.
USD 23.51
VCYT
-0.71
-2.93%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Natera, Inc.
USD 138.90
NTRA
-4.48
-3.12%
Illumina, Inc.
USD 96.14
ILMN
-1.79
-1.83%
Tempus AI, Inc.
USD 60.98
TEM
+0.33
0.54%
Veracyte, Inc.
USD 23.51
VCYT
-0.71
-2.93%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%